Menu
Innovative approaches to risk stratification and available tools
Summary
Definitions of risk-stratified screening will be developed. Risk assessment will be conducted and predictive models and risk calculators will be performed sharing results with WP10. Questions relevant for the HTA of the risk-stratified screenings will be identified. WP6 and WP4 tools will be adopted for evaluating barriers and WP4 preparedness to risk-stratified screening. Ethical and privacy concerns (genetic and non-genetic risks) will be addressed. A workshop to share the framework for evaluation with tasks 9.3, 9.4, and 9.5 will be organised. Feedback received from tasks 9.3, 9.4, 9.5 will be used to refine the framework and tools.
Task will be led by AUSLRE, Italy, co-led by CPO, Italy.
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959
